CD47 binds to SIRPα, a receptor in various bone marrow-derived cells, and functions as an innate inhibitory checkpoint that inhibits phagocytosis against tumor cells and the activation of downstream responses [24,25,26,27,28,29,34,35]. Here, SIRPA is linked to neoplasm.